Patent · US Active

Method for determining lymphoma type and providing treatment

US11646099B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 13, 2019
Grant dateMay 9, 2023
Priority date
Expiry dateNov 23, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

In embodiments of the invention, the invention provides a method for distinguishing between lymphoma types based on gene expression measurements. In embodiments, the invention distinguishes between PMBCL and DLBCL based on gene expression signatures, and can further distinguish between DLBCL subtypes. In embodiments of the invention, the distinctions are used in methods of treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.